Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway

Published:2022-04-12 Issue:5 Volume:47 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Tsao Ai-Ni¹,Chuang Yu-Syuan¹,Lin Yen-Chun¹,Su Yeu¹,Chao Ta-Chung²

Affiliation:

1. Institute of Biopharmaceutical Sciences, School of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 11200, Taiwan, R.O.C.

2. Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei 11200, Taiwan, R.O.C.

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference52 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Incidence and mortality and epidemiology of breast cancer in the world;Ghoncheh;Asian Pac J Cancer Prev,2016

3. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy;Nguyen;J Clin Oncol,2008

4. Gene-expression signatures in breast cancer;Sotiriou;N Engl J Med,2009

5. Optimal strategies for the treatment of metastatic triple-negative breast cancer with currently approved agents;André;Ann Oncol,2012

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the interplay between triple‐negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies;Journal of Cellular Physiology;2024-05-28

2. CD44 and its implication in neoplastic diseases;MedComm;2024-05-23

3. Therapeutic vulnerabilities in triple negative breast cancer: Stem-like traits explored within molecular classification;Biomedicine & Pharmacotherapy;2024-05

4. Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies;Medical Oncology;2024-04-09

5. Beyond cyclopamine: Targeting Hedgehog signaling for cancer intervention;Archives of Biochemistry and Biophysics;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3